Financial and Investment Analysts H-1B salary at Catalent Pharma Solutions: $115,000 average ($115,000-$115,000 range). 100% approval rate.
Catalent Pharma Solutions has filed 2 H-1B petitions for the Financial and Investment Analysts role, offering an average compensation of $115k. The average offered salary of $115k is 33% above the prevailing wage for this occupation. Most positions are located in Maryland (100%). The certification rate is 100%. 100% of these filings are for new employment.
| Total Filings | 2 |
| Approval Rate | 100% |
| Average Salary | $115,000 |
| Median Salary | $115,000 |
| 25th Percentile | $115,000 |
| 75th Percentile | $115,000 |
| Minimum Salary | $115,000 |
| Maximum Salary | $115,000 |
100% of filings offer salaries above the prevailing wage, with an average premium of 33.4%. The average prevailing wage is $86k (based on 2 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 7 days. Based on 2 filings.
100% of filings are for new positions, while 0% are for continued employment (2 filings with data).
Average contract duration: 36 months (median: 36 months), based on 2 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 2 |
| State | Filings |
|---|---|
| Maryland | 2 |
Catalent Pharma Solutions has 2 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at Catalent Pharma Solutions is $115,000, with a median of $115,000. Salaries range from $115,000 to $115,000.
The H-1B approval rate for Financial and Investment Analysts positions at Catalent Pharma Solutions is 100% based on 2 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.